Browsing by Author Fernandez-Penas, Pablo

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2009Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc.Fernandez-Penas, Pablo; Bi, Xiaohui; Chin, Lynda; Cohen, Lisa; Feng, Bin; Granter, Scott; Jaimes, Natalia; Lemos, Bianca; Leonard, J. Helen; Maher, Elizabeth; Nghiem, Paul; Paulson, Kelly; Western Clinical School: Medicine (Westmead)Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc., The Journal of Investigative Dermatology, vol.129, 6,pp 1547-1555
2012Bed bugs: clinical relevance and control optionsDwyer, Dominic; Fernandez-Penas, Pablo; Russell, Richard; Doggett, S L; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Bed bugs: clinical relevance and control options, Clinical Microbiology Reviews, vol.25, 1, 2012,pp 164-192
2012Cutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic MelanomaAnforth, Rachael; Fernandez-Penas, Pablo; Kefford, Richard (Rick); Long, Georgina; Scolyer, Richard; Blumetti, Tatiana Cristina Moraes Pinto; Kossard, Steven; Sharma, Raghwa; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: PathologyCutaneous Manifestations of Dabrafenib (GSK2118436): A Selective Inhibitor of Mutant BRAF in patients with Metastatic Melanoma, British Journal of Dermatology, vol.167, 5, 2012,pp 1153-1160
2013Cutaneous toxicities of RAF inhibitorsAnforth, Rachael; Fernandez-Penas, Pablo; Long, Georgina; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentreCutaneous toxicities of RAF inhibitors, Lancet Oncology, vol.14, 1, 2013,pp e11-e18
2012Kikuchi-Fujimoto disease with cutaneous presentation in a patient with subacute cutaneous lupus erythematosusFernandez-Penas, Pablo; Ruiz Beguerie, M (Julieta); Sharma, Raghwa; Western Clinical School: Medicine (Westmead); School of Public Health: School of Public Health Office; Western Clinical School: PathologyKikuchi-Fujimoto disease with cutaneous presentation in a patient with subacute cutaneous lupus erythematosus, Dermatology Online Journal, vol.18, 9, 2012,pp 1-5
2012Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHDFernandez-Penas, Pablo; Gottlieb, David; Hertzberg, Mark; George, B; George, L; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD, Bone Marrow Transplantation, vol.47, 5, 2012,pp 737-738
2012Lichen Planus-Like Drug Eruptions Due to [beta]-BlockersFernandez-Penas, Pablo; Fessa, Chris; Kossard, Steven; Lim, Penny; Richards, Shawn; Western Clinical School: Medicine (Westmead)Lichen Planus-Like Drug Eruptions Due to [beta]-Blockers, American Journal of Clinical Dermatology, vol.13, 6, 2012,pp 417-421
2010Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007)Fernandez-Penas, Pablo; Lim, Penny; Paver, Robert; Western Clinical School: Medicine (Westmead)Mohs micrographic surgery at the Skin and Cancer Foundation Australia, 10 years later (1997 vs 2007), Journal Of The American Academy Of Dermatology, vol.63, 5,pp 832-835
2012Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking braf inhibitorsAnforth, Rachael; Blumetti, Tatiana; Fernandez-Penas, Pablo; Tembe, Varsha; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking braf inhibitors, Pigment Cell and Melanoma Research, vol.25, 5, 2012,pp 569-572
2013Rational use of topical corticosteroidsCarlos Minano, Giuliana; Fernandez-Penas, Pablo; Pablo, Uribe; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead)Rational use of topical corticosteroids, Australian Prescriber, vol.36, 5, 2013,pp 158-161